资讯
The obstructive sleep apnea (OSA) market is being propelled by the rapid evolution of early detection and diagnostic tools. Technologies like home sleep apnea testing (HSAT), AI-powered applications, ...
Epitopea, a transatlantic cancer immunotherapeutics company developing accessible, off-the-shelf RNA-based immunotherapies, ...
ICMR and Panacea Biotec conduct third phase trials for indigenous dengue vaccine in India with promising results.
A recent study found that only 15% of cancer survivors discussed trials with their healthcare providers, with ...
Epitopea expands clinical development and research capabilities; forms research & clinical teams as it speeds up to clinical operations: Cambridge, UK Saturday, July 12, 2025, 16: ...
Multifaceted Mechanisms and Future of Diabetic Wound Healing and the rapidly evolving subject area, we are pleased to ...
The global clinical trials market is anticipated to grow at a CAGR of 6-7% from 2024 to 2029. This growth is driven by the increasing demand for personalized medicines, expansion in clinical research ...
5 天
Migraine Again on MSNIs Participating in a Migraine Clinical Trial Worth It? Benefits, Drawbacks, and What to ExpectConsidering a migraine clinical trial? Learn about the types, benefits, risks, and eligibility, along with what questions you should ask to see if participating is right for you.
Verastem Oncology releases primary results from phase 2 RAMP 201 trial of Avutometinib in combo with defactinib: Boston Tuesday, July 15, 2025, 09:00 Hrs [IST] Verastem Oncology, ...
BENGALURU: A series of clinical studies conducted at the National Institute of Mental Health and Neurosciences (NIMHANS) have ...
A new study published in the journal of Risk Management and Healthcare Policy showed that the frequency of magnesium ...
Lumos Diagnostics' shares more than doubled in value in afternoon trade after the biotech announced a US$317 million ($487 ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果